These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 9973516)

  • 21. PACAP inhibit the release and cytokine activity of HMGB1 and improve the survival during lethal endotoxemia.
    Tang Y; Lv B; Wang H; Xiao X; Zuo X
    Int Immunopharmacol; 2008 Dec; 8(12):1646-51. PubMed ID: 18713653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered anti-inflammatory response of mononuclear cells to neuropeptide PACAP is associated with deregulation of NF-{kappa}B in chronic pancreatitis.
    Michalski CW; Selvaggi F; Bartel M; Mitkus T; Gorbachevski A; Giese T; Sebastiano PD; Giese NA; Friess H
    Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G50-7. PubMed ID: 17962362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vasoactive intestinal peptide and pituitary adenylyl cyclase-activating polypeptide inhibit tumor necrosis factor-alpha production in injured spinal cord and in activated microglia via a cAMP-dependent pathway.
    Kim WK; Kan Y; Ganea D; Hart RP; Gozes I; Jonakait GM
    J Neurosci; 2000 May; 20(10):3622-30. PubMed ID: 10804204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymphocyte regulation of neuropeptide gene expression after neuronal injury.
    Armstrong BD; Hu Z; Abad C; Yamamoto M; Rodriguez WI; Cheng J; Tam J; Gomariz RP; Patterson PH; Waschek JA
    J Neurosci Res; 2003 Oct; 74(2):240-7. PubMed ID: 14515353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of IFN-gamma-induced janus kinase-1-STAT1 activation in macrophages by vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide.
    Delgado M; Ganea D
    J Immunol; 2000 Sep; 165(6):3051-7. PubMed ID: 10975815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vasoactive intestinal peptide (VIP) inhibits TGF-beta1 production in murine macrophages.
    Sun W; Tadmori I; Yang L; Delgado M; Ganea D
    J Neuroimmunol; 2000 Jul; 107(1):88-99. PubMed ID: 10808055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of the role of the PAC1 receptor in neutrophil recruitment, acute-phase response, and nitric oxide production in septic shock.
    Martínez C; Juarranz Y; Abad C; Arranz A; Miguel BG; Rosignoli F; Leceta J; Gomariz RP
    J Leukoc Biol; 2005 May; 77(5):729-38. PubMed ID: 15661828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors: distribution and involvement in the secretion of Podarcis sicula adrenal gland.
    Valiante S; Prisco M; Sciarrillo R; De Falco M; Capaldo A; Gay F; Andreuccetti P; Laforgia V; Varano L
    J Endocrinol; 2008 Feb; 196(2):291-303. PubMed ID: 18252952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary.
    Barberi M; Muciaccia B; Morelli MB; Stefanini M; Cecconi S; Canipari R
    Reproduction; 2007 Aug; 134(2):281-92. PubMed ID: 17660238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide stimulate the induction of Th2 responses by up-regulating B7.2 expression.
    Delgado M; Leceta J; Gomariz RP; Ganea D
    J Immunol; 1999 Oct; 163(7):3629-35. PubMed ID: 10490956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pituitary adenylate cyclase-activating polypeptide and PACAP receptor expression and function in the rat adrenal gland.
    Mazzocchi G; Malendowicz LK; Neri G; Andreis PG; Ziolkowska A; Gottardo L; Nowak KW; Nussdorfer GG
    Int J Mol Med; 2002 Mar; 9(3):233-43. PubMed ID: 11836629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit tumor necrosis factor alpha transcriptional activation by regulating nuclear factor-kB and cAMP response element-binding protein/c-Jun.
    Delgado M; Munoz-Elias EJ; Kan Y; Gozes I; Fridkin M; Brenneman DE; Gomariz RP; Ganea D
    J Biol Chem; 1998 Nov; 273(47):31427-36. PubMed ID: 9813054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. cAMP activation by PACAP/VIP stimulates IL-6 release and inhibits osteoblastic differentiation through VPAC2 receptor in osteoblastic MC3T3 cells.
    Nagata A; Tanaka T; Minezawa A; Poyurovsky M; Mayama T; Suzuki S; Hashimoto N; Yoshida T; Suyama K; Miyata A; Hosokawa H; Nakayama T; Tatsuno I
    J Cell Physiol; 2009 Oct; 221(1):75-83. PubMed ID: 19496170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: players in innate and adaptive immunity.
    Ganea D; Rodriguez R; Delgado M
    Cell Mol Biol (Noisy-le-grand); 2003 Mar; 49(2):127-42. PubMed ID: 12887096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. VIP and PACAP enhance IL-6 release and mRNA levels in resting peritoneal macrophages: in vitro and in vivo studies.
    Martinez C; Delgado M; Pozo D; Leceta J; Calvo JR; Ganea D; Gomariz RP
    J Neuroimmunol; 1998 May; 85(2):155-67. PubMed ID: 9630164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exogenous VIP limits zymosan-induced generalized inflammation (ZIGI) in mice.
    Ivanovska N; Kalfin R; Lazarova M; Dimitrova P
    Immunol Lett; 2007 Jun; 110(2):126-32. PubMed ID: 17532056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide inhibit the MEKK1/MEK4/JNK signaling pathway in LPS-stimulated macrophages.
    Delgado M; Ganea D
    J Neuroimmunol; 2000 Oct; 110(1-2):97-105. PubMed ID: 11024538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The inhibitory effects of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide on osteoclast formation are associated with upregulation of osteoprotegerin and downregulation of RANKL and RANK.
    Mukohyama H; Ransjö M; Taniguchi H; Ohyama T; Lerner UH
    Biochem Biophys Res Commun; 2000 Apr; 271(1):158-63. PubMed ID: 10777696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fgl2 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response.
    Ning Q; Brown D; Parodo J; Cattral M; Gorczynski R; Cole E; Fung L; Ding JW; Liu MF; Rotstein O; Phillips MJ; Levy G
    J Immunol; 1998 Apr; 160(7):3487-93. PubMed ID: 9531310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The neuropeptides vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) modulate several biochemical pathways in human leukemic myeloid cells.
    Hayez N; Harfi I; Lema-Kisoka R; Svoboda M; Corazza F; Sariban E
    J Neuroimmunol; 2004 Apr; 149(1-2):167-81. PubMed ID: 15020077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.